Results 81 to 90 of about 1,421,660 (159)
Objectives To assess reliability of the two indexes of Localized Scleroderma Cutaneous Assessment Tool (LoSCAT), the modified Localized Scleroderma Skin Severity Index (mLoSSI) and the Localized Scleroderma Skin Damage Index (LoSDI), when applied by ...
Anna Agazzi+4 more
doaj +1 more source
MicroRNA in localized scleroderma: a review of literature
Localized scleroderma (LoSc) is rare connective tissue disease that manifests with inflammation and fibrosis of the skin. Depending on the LoSc subtype, adjacent structures such as subcutaneous tissue, fascia, muscles, bones may be affected. The hallmark
Katarzyna Wolska-Gawron+2 more
semanticscholar +1 more source
Ultrasonography, MRI and classic radiography of skin and MSK involvement in juvenile scleroderma
Scleroderma is a rare, autoimmune, chronic condition that affects the connective tissue by excessive collagen production. If diagnosed before the age of 16, it is referred to as juvenile scleroderma.
Idzior Marta+4 more
doaj +1 more source
Objective. To perform a comparative effectiveness feasibility study in juvenile localized scleroderma (LS), using standardized treatment regimens (consensus treatment plans; CTP). Methods.
Suzanne C. Li+14 more
semanticscholar +1 more source
Parry-Romberg Syndrome Associated with Localized Scleroderma
Parry-Romberg syndrome is a rare neurocutaneous disorder of unknown origin. It is characterized by progressive facial hemiatrophy and frequently overlaps with a condition known as linear scleroderma ‘en coup de sabre’.
Jelena Maletic+4 more
doaj +1 more source
A case of localized bullous scleroderma
Bullous scleroderma is a rare type of the focal form of the disease mainly affecting the skin and characterized by induration and sclerosis foci as well as subepidermal blisters containing a transparent matter.
A. L. Bakulev+3 more
doaj +1 more source
Localized scleroderma (morphea) is a chronic autoimmune disease of the connective tissue. Its etiopathogenesis is unknown. Most often the disease affects the skin, but may also involve the subcutis, muscles, and the osteoarticular system.
D. Krasowska+10 more
semanticscholar +1 more source
According to current standards, no existing patient‐reported outcome (PRO) measures have high‐quality validity evidence for use with individuals diagnosed with paediatric localized scleroderma (LS).
C. Zigler+4 more
semanticscholar +1 more source
Experience with Lipofilling in Children with Localized Scleroderma: Case Study
Background. Localized scleroderma (LS) is an inflammatory sclerosing disease of unknown etiology. It is characterized by progressive lesion of connective tissue leading to sclerosis and/or atrophy of the skin and underlying tissues.
Alina R. Misbakhova+4 more
doaj +1 more source